Gilead Sciences, Inc. · NASDAQ:GILD
Kramer Kelly A. sold 10,376 Gilead Sciences, Inc. shares (Form 4)
Traded Nov 12, 2026 · Filed Nov 16, 2026
On Nov 12, 2026, Kramer Kelly A. (Director) sold 10,376 Gilead Sciences, Inc. shares at an average US$169.76 for US$1.76M under a trading plan, leaving 1,339 shares. Filed Nov 16, 2026 (Form 4).
- Sold
- 10,376 shares
- Price
- US$169.76 average (US$168.23 to US$171.44)
- Value
- US$1.76M
- Holding after
- 1,339 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Common Stock | Option exercise | 10,376 | US$66.92 | 11,715 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 1,676 | US$168.23 | 10,039 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 3,800 | US$169.44 | 6,239 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 4,700 | US$170.49 | 1,539 | Direct |
| Nov 12, 2026 | Common Stock | Sale | 200 | US$171.44 | 1,339 | Direct |
Source
Download original · View original at SEC